Professional Summary

Professional Overview

Bob Goeltz is a seasoned Chief Financial Officer with extensive experience in the biotechnology and pharmaceutical industries. He possesses a proven track record of driving financial strategy, optimizing operations, and facilitating business growth. Goeltz's industry expertise and leadership capabilities have contributed to the success of several prominent life sciences organizations.

Experience Summary

Current Role

Goeltz currently serves as the Chief Financial Officer at Arcus Biosciences, a clinical-stage biopharmaceutical company focused on developing innovative cancer therapies. In this role, he is responsible for overseeing the company's financial operations, including financial planning, reporting, and risk management. Goeltz's strategic financial guidance has been instrumental in supporting Arcus Biosciences' continued growth and advancement of its pipeline.

Career Progression

Prior to joining Arcus Biosciences, Goeltz held CFO positions at several other prominent biotechnology companies, including UNITY Biotechnology, CytomX Therapeutics, and Onyx Pharmaceuticals. He also held various finance leadership roles at Amgen, a leading global biopharmaceutical company, where he gained valuable experience in corporate development, commercial finance, and R&D finance. Goeltz's extensive background in the life sciences sector has equipped him with a deep understanding of the industry's complex financial and operational challenges.

Academic Background

Goeltz holds a Bachelor of Science degree in Accounting from the University of California, Berkeley. He is a Certified Public Accountant (CPA) and has a strong foundation in financial reporting, analysis, and strategic planning.

Areas of Expertise

• Financial strategy and planning

• Operational optimization and efficiency

• Regulatory compliance and risk management

• Mergers, acquisitions, and corporate development

• Investor relations and capital markets

• Leadership and team building

Professional Impact

During his tenure as CFO, Goeltz has played a pivotal role in securing funding, optimizing financial operations, and supporting the growth and expansion of the companies he has served. His strategic financial guidance and operational expertise have been instrumental in helping these organizations navigate complex industry challenges and achieve their strategic objectives.

Conclusion

With his extensive experience in the biotechnology and pharmaceutical industries, Goeltz is a highly sought-after finance leader. His proven track record of driving financial excellence, facilitating business growth, and supporting the advancement of innovative therapies positions him as a valuable asset to Arcus Biosciences and the broader life sciences community.